Nitrase Therapeutics jobs and careers
Brisbane, CA, United States
About Nitrase Therapeutics
Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes that it discovered, to develop a pipeline of therapies against a broad variety of diseases. The medicines that Nitrase Therapeutics is developing will target these enzymes and potentially help slow or halt the progression of a wide variety of diseases in which nitrases and nitro-substrates play a role, including Parkinson’s and cancer. Nitrase Therapeutics (under the former name Nitrome Biosciences) has been widely recognized and has won multiple awards including the prestigious Target Advancement grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).
Founded in 2017 by Irene Griswold-Prenner.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $45.1M
- Headquarters
- Brisbane
Leadership
The top of Nitrase Therapeutics's org chart, with how many people report into each leader.
Irene Griswold-Prenner
CEO & Chief Scientific Officer
8 reports
Frank Kayser
VP Drug Discovery
6 reports
Carla Ramos
Director Of Operations
Board
James Summers
Chairperson, Scientific Advisory Board
Eric Yuen
Scientific Advisor
Perry Karsen
Chair Of The Board Of Directors
Henrijette Richter
Director
Harry Ischiropoulos
Scientific Advisor
Regis B. Kelly
Scientific Advisor
Jobs at Nitrase Therapeutics
No open positions right now. Explore more companies on TheJobsMap.